Envestnet Asset Management Inc. Trims Stock Position in Integer Holdings Corporation (NYSE:ITGR)

Envestnet Asset Management Inc. decreased its position in Integer Holdings Corporation (NYSE:ITGR) by 1.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 238,710 shares of the medical equipment provider’s stock after selling 3,906 shares during the quarter. Envestnet Asset Management Inc. owned 0.68% of Integer worth $28,170,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Lee Danner & Bass Inc. purchased a new stake in Integer in the fourth quarter valued at approximately $27,000. Opal Wealth Advisors LLC acquired a new position in shares of Integer in the first quarter worth $28,000. AdvisorNet Financial Inc acquired a new position in shares of Integer in the first quarter worth $28,000. Bessemer Group Inc. grew its stake in shares of Integer by 73.1% in the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider’s stock worth $35,000 after acquiring an additional 125 shares in the last quarter. Finally, Sterling Capital Management LLC grew its stake in shares of Integer by 472.9% in the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 279 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Stock Down 0.3%

ITGR stock opened at $119.61 on Tuesday. The company’s 50 day simple moving average is $119.91 and its 200-day simple moving average is $124.82. The firm has a market capitalization of $4.17 billion, a PE ratio of 56.69, a P/E/G ratio of 1.03 and a beta of 0.98. Integer Holdings Corporation has a 12 month low of $104.93 and a 12 month high of $146.36. The company has a debt-to-equity ratio of 0.78, a current ratio of 3.40 and a quick ratio of 2.14.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Integer had a net margin of 4.38% and a return on equity of 11.95%. The firm had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. During the same quarter last year, the business earned $1.14 earnings per share. Integer’s revenue was up 7.3% compared to the same quarter last year. Equities analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have issued reports on ITGR. Citigroup upgraded shares of Integer from a “hold” rating to a “strong-buy” rating and upped their price objective for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Raymond James Financial upped their target price on shares of Integer from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, April 25th. KeyCorp lowered their target price on shares of Integer from $154.00 to $145.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. Wall Street Zen upgraded shares of Integer from a “sell” rating to a “hold” rating in a research report on Monday, May 19th. Finally, Benchmark lowered their target price on shares of Integer from $150.00 to $140.00 and set a “buy” rating on the stock in a research report on Friday, April 25th. Two investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $145.00.

Insider Buying and Selling

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the transaction, the chief executive officer owned 47,000 shares of the company’s stock, valued at $5,788,990. This trade represents a 87.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the transaction, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. This represents a 28.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 362,434 shares of company stock worth $44,577,115. 2.16% of the stock is owned by insiders.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.